<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03948893</url>
  </required_header>
  <id_info>
    <org_study_id>2020602</org_study_id>
    <nct_id>NCT03948893</nct_id>
  </id_info>
  <brief_title>Smoking Cessation Behavioral Treatment Study</brief_title>
  <official_title>Neural Mechanisms Mediating Appetitive Regulation and Smoking in Nicotine Addiction</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Missouri-Columbia</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Medical University of South Carolina</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Missouri-Columbia</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the effectiveness of two behavioral interventions on&#xD;
      smoking behavior - Mindfulness-Oriented Recovery Enhancement (MORE) and Cognitive Behavioral&#xD;
      Therapy (CBT). MORE is a behavioral therapy that integrates mindfulness training to modify&#xD;
      reward processes. CBT is a therapy designed to help individuals understand how their thoughts&#xD;
      and feelings influence their behaviors.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 19, 2019</start_date>
  <completion_date type="Anticipated">July 31, 2024</completion_date>
  <primary_completion_date type="Anticipated">July 31, 2024</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Cigarette Smoking</measure>
    <time_frame>7 weeks</time_frame>
    <description>Biochemical smoking assessment (breath carbon monoxide) at each study visit.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Magnitude of change in fMRI brain response to images</measure>
    <time_frame>7 weeks</time_frame>
    <description>Measure the effects of MORE on fMRI BOLD response to images (change from baseline to end of study) while participants undergo functional magnetic resonance imaging</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Magnitude of change in fMRI brain connectivity</measure>
    <time_frame>7 weeks</time_frame>
    <description>Measure the effects of MORE on resting-state functional connectivity (change from baseline to end of study) while participants undergo functional magnetic resonance imaging.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Tobacco Use Disorder</condition>
  <arm_group>
    <arm_group_label>MORE</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>CBT</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Mindfulness-Oriented Recovery Enhancement (MORE)</intervention_name>
    <description>MORE is a behavioral therapy that integrates mindfulness training to modify reward processes.</description>
    <arm_group_label>MORE</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Cognitive Behavioral Therapy (CBT)</intervention_name>
    <description>CBT is a therapy designed to help individuals understand how their thoughts and feelings influence their behaviors.</description>
    <arm_group_label>CBT</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age 18 and up&#xD;
&#xD;
          -  English fluency as demonstrated in providing informed consent and the ability to&#xD;
             independently follow directions in completing assigned assessments and tasks&#xD;
&#xD;
          -  Functional vision (with corrective lenses as needed) to complete assigned assessments&#xD;
             and tasks&#xD;
&#xD;
          -  Current nicotine dependent smoker with a minimum smoking history of 2 years&#xD;
&#xD;
          -  Interest in quitting smoking&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Use of psychotropic (e.g. antiepileptic) medications in the past month&#xD;
&#xD;
          -  Positive urine drug screen&#xD;
&#xD;
          -  Presence of an untreated medical illness&#xD;
&#xD;
          -  Current or past psychosis&#xD;
&#xD;
          -  History of major neurological illness or head injury resulting in loss of&#xD;
             consciousness&#xD;
&#xD;
          -  And contraindication to MRI, including claustrophobia&#xD;
&#xD;
          -  Among females, positive urine pregnancy test&#xD;
&#xD;
          -  Inability or unwillingness of subject to give informed consent&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Madhura Athreya, MS</last_name>
    <phone>5738822977</phone>
    <email>athreyam@health.missouri.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Brett Froeliger, PhD</last_name>
    <phone>5738824785</phone>
    <email>froeligerb@health.missouri.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of Missouri - Columbia</name>
      <address>
        <city>Columbia</city>
        <state>Missouri</state>
        <zip>65211</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Brett Froeliger, PhD</last_name>
      <phone>573-882-4785</phone>
      <email>froeligerb@health.missouri.edu</email>
    </contact>
    <contact_backup>
      <last_name>Madhura Athreya, MS</last_name>
      <phone>5738822799</phone>
      <email>athreyam@health.missouri.edu</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Medical University of South Carolina</name>
      <address>
        <city>Charleston</city>
        <state>South Carolina</state>
        <zip>29425</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Michael Saladin, PhD</last_name>
      <phone>843-792-5306</phone>
      <email>saladinm@musc.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2020</verification_date>
  <study_first_submitted>May 10, 2019</study_first_submitted>
  <study_first_submitted_qc>May 10, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">May 14, 2019</study_first_posted>
  <last_update_submitted>November 17, 2020</last_update_submitted>
  <last_update_submitted_qc>November 17, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">November 19, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Missouri-Columbia</investigator_affiliation>
    <investigator_full_name>Brett Froeliger</investigator_full_name>
    <investigator_title>Professor Psychiatry</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tobacco Use Disorder</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

